Prison systems, with the ability to reject or approve applications for conducting research with incarcerated populations, function as shapers of carceral knowledge and thus can potentially close opportunities for new qualitative studies as well as affect the quality and richness of the data obtained. This article describes a collaborative research process wherein access to current prisoners was not granted, and only former prisoners who were not on parole were eligible to participate in the study. We provide a unique reflective analysis of how access barriers altered the scope of our research and may have impacted our findings were it not for a change in our recruitment plan. We also incorporate insights from multiple literatures that speak to the value, challenges, and ethical concerns associated with doing research with former prisoners. Our contribution to the qualitative carceral literature sparks new questions worthy of further in-depth exploration, in particular how to more meaningfully involve former prisoners in the research process.
Community stakeholders express a range of opinions about supervised injection facilities (SIFs). We sought to identify reasons for ambivalence about SIFs amongst community stakeholders in two Canadian cities. We used purposive sampling methods to recruit various stakeholder representatives (n = 141) for key informant interviews or focus group discussions. Data were analyzed using a thematic process. We identified seven reasons for ambivalence about SIFs: lack of personal knowledge of evidence about SIFs; concern that SIF goals are too narrow and the need for a comprehensive response to drug use; uncertainty that the community drug problem is large enough to warrant a SIF(s); the need to know more about the “right” places to locate a SIF(s) to avoid damaging communities or businesses; worry that a SIF(s) will renew problems that existed prior to gentrification; concern that resources for drug use prevention and treatment efforts will be diverted to pay for a SIF(s); and concern that SIF implementation must include evaluation, community consultation, and an explicit commitment to discontinue a SIF(s) in the event of adverse outcomes. Stakeholders desire evidence about potential SIF impacts relevant to local contexts and that addresses perceived potential harms. Stakeholders would also like to see SIFs situated within a comprehensive response to drug use. Future research should determine the relative importance of these concerns and optimal approaches to address them to help guide decision-making about SIFs.